Draft Guideline on the quality of water for pharmaceutical use
Following the 2017 EMA concept paper, please find attached a draft guideline on the quality of water for pharmaceutical use. This replaces (CPMP/QWP/158/01, EMEA/CVMP/115/01) originally adopted in May 2002, and the CPMP Position Statement on the Quality of Water used in the production of Vaccines for parenteral use (EMEA/CPMP/BWP/1571/02 rev.1).
Comments on the draft should be sent via the attached form to Piero Iamartino and are requested before the end of March 2019.
Jane Nicholson BPharm.FRPharm.S.FTOPRA
Executive Director EIPG